December 2020 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- View From The Inside: What’s Shaping Biopharma In 2021 And Beyond?
- From “Musty Towel” To “Golden Age:” Biosimilars In 2021 And Beyond
- COVID-19 And Cell And Gene Sector: Contingency Planning For 2021 And Beyond
- Reflection And Projection — 15 CEOs Map Biopharma’s Present And Future
- AI And Machine Learning Prepare Pharma For The Data Onslaught
- Politics and the Pandemic — Where Are They Taking Biopharma? Industry CEOs Speak Out
- What Do 10 Biopharma Finance Experts Expect for 2021?
- The Future Of Biopharma Manufacturing Has Never Been More Critical
- Can Your CDMO Relationships Survive Another “Virtual” Year?
Capitol Perspectives
From Policy to Execution
Industry Research
Leadership Lessons
This website uses cookies to ensure you get the best experience on our website. Learn more